Miko

The biggest hurdle to reaching this $6–$10 price target is cash. $SGMO is "partner-hunting." An official partnership announcement with a company (like Eli Lilly or Roche) would likely be the first major move, potentially doubling the stock before the FDA even makes a decision.

$SGMO video presentation: #fpstate=ive&vld=cid:6030f081,vid:qXwt4TdeqSw,st:0" target="_blank" rel="nofollow noopener">google.com/search?q=https…

Per Gemini on $SGMO Submission Status: Sangamo advanced its Rolling BLA Submission on March 9, 2026. Completion Target: They expect to complete the full submission in Q2 2026 (April–June).

Per Gemini on $SGMO :Historical Benchmarks: Similar gene therapy companies have been acquired for $8 Billion to $12 Billion (e.g., AveXis or Kite Pharma).

Per Gemini on $SGMO : If a "Big Pharma" company buys SGMO to get their hands on the STAC-BBB platform (which helps drugs cross into the brain), the price could easily exceed the $10.00+ range.

@GamalielBaer @whistlesauger @kaysaaa81 @BiotechAnalysst @BPharmCatalyst @Franca_ole @ZinselmeyerB Well shit Grok can't be wrong - I'm down for another 10k share add $SGMO to my bags tomorrow!

@whistlesauger @kaysaaa81 @BiotechAnalysst @BPharmCatalyst @Franca_ole @ZinselmeyerB $sgmo This is grok giving a hypothetical valuation of ONLY a "safe, repeatable/reproducible BBB crossing delivery system that can carry universal gene editing platform.

@BiotechAnalysst @BPharmCatalyst @Franca_ole @ZinselmeyerB $SGMO Ran a Monte Carlo simulation, 2,000 runs randomizing 35 inputs across four valuation models. Partnership, go-alone, outright sale, full acquisition. 23 inputs displayed on the spreadsheet, the rest under the hood. Every assumption stress-tested from pessimistic to optimistic simultaneously. Not one run out of 2,000 produced an intrinsic value below $1.40. That's why I'm strictly personally optimistic. Not investment advice.

@merlin_trader Really good layout of what $SGMO is all about for investors - thanks!

Sangamo Therapeutics ( $SGMO ) – Fabry BLA, delivery platform and dilution risk merlintrader.com/sangamo-therap…

@mhp_guy How can I get the business plan??

This woman is making well over $1,000 serving ramen to people at an event. Costs per person: 50 cents to $1.50 She charges: Between $7 and $15 per head You should start this, like yesterday.

@RedPandaKoala It's called an alcoholic 'black-out'

🚨 A top U.S. government official at FEMA says he was teleported to a Waffle House against his will “It was scary, you don’t really know if it’s evil or if it's good. I was on the phone and landed about 40 miles away in a ditch. It was an incredibly frightening moment to experience yourself in your car flying through the air. I ended up at a Waffle House fifty miles away from where I was.”

If I were on the inside of $SGMO and had faith we are sitting on a potential 10x you would think they would jump in for 500,000 shares at this price and turn $165K into $1.6 Mil... so you have to wonder just how much faith they have going forward

@BITCOINFUNDMGR How can I learn more about having you manage part of my investments?

RARE BEHIND THE SCENES SNEAK PEEK AT HOW QUANT HEDGE FUND MANAGERS TRADE You hire a fund manager to make you 500% profit every year. Most fund managers only make you 15 to 20%. You'd be better off just holding QQQ. But some fund managers will make you 10x or even 100x your money within a year. You know the difference is? This video explains how shorts and longs actually work behind the scenes. And it shows you how much of a war zone the exchanges actually are. When you start looking under the hood, you'll be able to see why some hedge funds only give you 20% annual profit and others can give you 10x or 100x. This should be eye-opening.

@etrade finally got someone to answer - When they answer please be polite - not the fault of the rep - so keep it civil but do emphasize that being a customer is probably no longer in your best interest if you want to vent

@etrade still on hold after 70 minutes! WOW total failure!

@etrade now holding for 45 minutes!!!!! WTF!

@etrade Been on hold for 35 minutes - I don't think I want to keep my account with a brokerage that takes that long to respond to my call... This is the first time in years I've called - @SchwabTrading answered in a few minutes

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its fourth quarter and full year 2025 financial results after the market closes on Monday, March 30, 2026. $SGMO I can't wait to hear this!

It would be helpful if $SGMO put out a PR recapping where we stand on events in motion, awaiting events and goals ... give us something to have proof of life in that office anyways

How can anyone not give up on $SGMO at this point - the company has not given a freaking thing for us to feel like they are working for their investment partners... Did Sandy or any other high paying positions buy more shares or take a pay cut? NO

With all the assets they have and pending fast-track approval you would think at this price a $LLY or $MRNA would jump in and take over $SGMO just by becoming a majority shareholder...

Almost going to make a new 52 week low - and management has nothing to say? $SGMO has been my worse idea of an investment in 30 years - WTF